Ara
Toplam kayıt 38, listelenen: 21-30
Leflunomide as a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis
(Wiley, 2018)
[No Abstract Available]
Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
(Amer Soc Hematology, 2019)
[No Abstract Available]
GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.
(Amer Soc Clinical Oncology, 2019)
[No Abstract Available]
Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data
(Amer Soc Hematology, 2019)
[No Abstract Available]
The effect of ezetimibe monotheraphy on mean platelet volume in patients with hyperlipidaemia: a retrospective study of 45 patients
(Pakistan Medical Assoc, 2016)
Objective: To investigate the effect of ezetimibe on platelet functions as a drug which increases mevalonate levels. Methods: This retrospective study was conducted in Istanbul, Turkey, and comprised record of normolipidaemic ...
Peripheral Blood CD34+ Cell Counts in Patients With Severe Sepsis
(Turkish Soc Immunology, 2016)
Objectives: This study aims to determine the impact of severe sepsis (SS) on CD34(+) cell counts in the peripheral blood and to compare these counts with those of healthy subjects. Patients and methods: CD34(+) cell counts ...
Use of Eltrombopag in Immune Thrombocytopenia in Turkey
(Pergamon-Elsevier Science Ltd, 2016)
[No Abstract Available]
The concentration of some trace elements (Al, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Ag, Cd, V, Hg and Pb) in the colorectal polyp tissues
(Wiley-Blackwell, 2016)
[No Abstract Available]
Carotid intima-media thickness and serum paraoxonase-1 activity in patients with Helicobacter pylori
(Verduci Publisher, 2013)
AIM: To evaluate serum paraoxonase(PON)-1 activity and carotid intima-media thickness (CIMT) in patients with Cytotoxin-associated antigen(CagA)-positive and negative Helicobacter pylori strains. PATIENTS AND METHODS: The ...